
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.66016
Pathology
Dermatology
Calcinosis Cutis Inducing "Syringomatoid" Eccrine Hyperplasia: An Extremely Rare Example
Muacevic Alexander
Adler John R
Hussain Umar A 1
Ahuero Audrey E 2
Tschen Jamie A 3
1 Histopathology, Manchester University NHS Foundation Trust, Manchester, GBR
2 Ophthalmology, Ophthalmic Plastic Surgeons of Texas, Houston, USA
3 Dermatopathology, St. Joseph Hospital, Houston, USA
Umar A. Hussain umarhussain@doctors.org.uk
2 8 2024
8 2024
16 8 e6601625 7 2024
Copyright © 2024, Hussain et al.
2024
Hussain et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/272055-calcinosis-cutis-inducing-syringomatoid-eccrine-hyperplasia-an-extremely-rare-example
Reactive “syringomatoid” eccrine proliferations are a well-established phenomenon, which can show similar but less extensive histological features of a syringoma. The cut-off between syringomatoid hyperplasia and syringomas is subjective and given the considerable morphological overlap, it is possible they represent two points on the same spectrum. Syringomatoid hyperplasia has been associated with several conditions including neoplasms and inflammatory dermatoses. Herein, we describe an extremely rare case of syringomatoid hyperplasia occurring with calcinosis cutis in a 54-year-old Caucasian male. To the best of the authors’ knowledge, this is the first such case described in the literature.

hyperplasia
eccrine duct
calcinosis
calcinosis cutis
eccrine hyperplasia
syringoma
syringomatoid
==== Body
pmcIntroduction

Syringomas are well-recognized benign skin adnexal tumours that typically present as small flesh-coloured papules on the eyelids [1,2]. Histologically, they show “comma-shaped” or “tadpole” eccrine ductular nests typically confined to the superficial dermis - features that are so well recognised that they have almost become synonymous with syringoma [2]. However, hyperplastic eccrine proliferations producing similar “syringomatoid” ducts have long been recognized in the literature and have been described in association with inducing pathologies, such as neoplasms or inflammatory dermatoses [3]. We will be using the term “syringomatoid hyperplasia” to describe this phenomenon, but other terms such as “syringomatous dermatitis” have also been suggested [4]. Herein, we describe an extremely rare case of syringomatoid hyperplasia occurring with calcinosis cutis in a 54-year-old Caucasian male.

Case presentation

A 54-year-old Caucasian male presented to the ophthalmologist with a one-year history of a lesion on the right lower eyelid. There were no symptoms related to the lesion except for a slight increase in size. He had a past medical history of hypothyroidism, gastroesophageal reflux disease, sleep apnea and arthritis. Regular medications included levothyroxine and omeprazole. There was no relevant family history. On examination, there was a 4mm firm papule present on the right lower eyelid (Figure 1). The clinical differential diagnosis included syringoma, sebaceous hyperplasia, seborrheic keratosis and, less likely, basal cell carcinoma (BCC). The lesion was surgically excised and sent to the pathology laboratory for further analysis.

Figure 1 An isolated 4mm papule present on the right lower eyelid consisting of multiple white micronodules (arrow). The patient also shows features of rosacea.

Histology of the lesion showed large, calcified nodules occupying much of the superficial dermis (Figure 2). The overlying epidermis was unremarkable. On higher power, numerous bilayered, comma-shaped ductular nests were discovered adjacent to the calcification in the superficial dermis (Figure 3 and Figure 4). Some of these ducts showed mild infiltration by chronic inflammatory cells. Further inspection noted that the calcified nodules were contained within a bilayered ductular epithelium identical to the ductular components described. No other abnormality was present. The case was signed out as calcinosis cutis with syringomatous changes. The patient did not report any recurrence or further lesions since the excision.

Figure 2 This low-power-view image shows heavily calcified dermal nodules (arrows) with unremarkable overlying epidermis. Taken in context of the whole lesion, the syringomatous component is scanty and almost unnoticeable at this power.

Figure 3 High-power-view shows tear-drop-shaped “syringomatoid” nests (black arrows) immediately adjacent to calcification (white asterisk) located within a dilated sweat duct (white arrow). Note that the ductal cells lining the calcified area show nearly identical appearance to the syringomatoid nests. Focal lymphocytic infiltrate is seen involving a couple of the ductal structures in this image (white triangles) – a finding described in other cases of syringomatoid hyperplasia.

Figure 4 Another high-power view demonstrating calcification (asterisk) occupying a dilated eccrine duct (white arrow) with more typical comma-shaped ducts adjacent (black arrows).

Discussion

Syringomas are well-recognized benign skin adnexal tumors believed to arise from the acrosyringium [1]. They typically present as small flesh-colored papules on the eyelids [2]. Histologically, they demonstrate bland, bilayered comma-shaped or tadpole eccrine ducts in the superficial dermis [2]. Reactive eccrine ductal proliferations producing similar “syringomatoid” ducts have long been described in the literature [3]. The comma-shaped appearance of the ducts is a product of cross-sectioning of hypercoiled glands [3]. Numerous skin conditions have been implicated as the driving pathology and presumably occur as a consequence of ductal obstruction or direct irritation of the eccrine ducts themselves (see Table 1).

Table 1 Lesions described with eccrine ductal proliferation

Table credits: Authors' creation. All information obtained is from [3] unless a separate citation is present.

SCC: Squamous cell carcinoma; BCC: Basal cell carcinoma

Category	Entity	
Epithelial neoplasms	Keratoacanthoma	
SCC	
Superficial BCC	
Melanocytic neoplasms	Melanocytic naevi	
Malignant Melanoma	
Inflammatory and other dermatoses	Eczema [4]	
Prurigo nodularis [5]	
Lichen planus	
Pityriasis lichenoides chronica	
Acne rosacea	
Scarring and non-scarring alopecia [6]	
Epidermolysis bullosa	
Chondrodermatitis nodularis helicis	
Porphyria cutanea tarda	
Porokeratosis of Mibelli	
Other lesions	Trichilemmal cyst	
Fibroma	
Nasal glioma [7]	
Calcinosis cutis [this case]	

The cut-off between syringomatoid hyperplasia and syringomas is somewhat subjective. Generally, syringomatoid hyperplasia is less extensive than syringoma and would have some sort of inducing factor, such as a neoplasm or inflammatory insult. Interestingly, some authors believe the variant of syringoma, known as eruptive syringoma, which is characterized by the sudden eruption of multiple syringomas on two or more anatomical parts, is in fact a form of syringomatoid hyperplasia which is hormonally driven [2, 4]. It is possible that syringomatoid hyperplasia and syringoma represent two points on a spectrum of reactive eccrine ductular proliferations. No inciting gene mutation for syringomas has ever been described, further adding weight to this theory.

In our case, we observed an isolated skin lesion on the eyelid, which was composed primarily of calcification (i.e., calcinosis cutis) and possessed a lesser component of syringomatous ducts. Calcinosis cutis is a category of skin lesions characterized by calcium-salt deposition in the soft tissue of the skin and can broadly be considered as dystrophic, metastatic or idiopathic (Table 2). We considered the possibility that the histological findings identified in our case could have represented a syringoma with dystrophic calcification - after all, calcification occurring in syringomas has been described, albeit rarely [8-16]. In general, the degree of calcification in these cases was relatively mild in comparison to what we observed in our case. In our view, the relative scarcity of reports of dystrophic calcification in syringomas, the extensiveness of the calcification, the presence of a solitary rather than multiple lesions on the eyelid and the age of the patient favor a diagnosis of calcinosis cutis-inducing syringomatoid hyperplasia, rather than syringoma. However, the possibility of prominent dystrophic calcification occurring in a syringoma, especially as the lesion was present at a typical site, cannot be entirely excluded.

Table 2 Subtypes of calcinosis cutis

Table credits: Authors' creation using information from [17].

Subtype of calcinosis cutis	Distinguishing features	
Dystrophic calcification	Cutaneous calcium deposition developing in lesional tissue in the setting of normal calcium/phosphate levels	
Metastatic calcinosis cutis	Cutaneous calcium deposition in the setting of abnormal calcium and/or phosphate metabolism and no evidence of background lesional skin (i.e., hypercalcemia or hyperphosphatemia)	
Idiopathic calcinosis cutis	Cutaneous calcium deposition occurring in the setting of no apparent background skin lesion and no calcium or phosphate metabolic abnormality. Well-known examples include scrotal calcinosis, tumoral calcinosis (periarticular skin) and solitary calcified nodules (face of children)	
Iatrogenic calcinosis cutis	Cutaneous calcium deposition related to certain treatments e.g. IV calcium gluconate, subcutaneous para-aminosalicylic acid, blood products, post-transplant	
Calciphylaxis	Cutaneous calcium deposition located in the walls of small vessels of the dermis and subcutaneous fat, usually in the setting of end-stage renal disease	

To the best of our knowledge, this is the first reported case of syringomatoid hyperplasia with calcinosis cutis, although it should be mentioned that a report by Maroon et al. in 1990 [16] demonstrated calcinosis cutis with multiple syringomas, which in hindsight may have represented syringomatoid hyperplasia rather than syringomas, but this is difficult to conclude without reviewing the case.

Conclusions

To the best of our knowledge, this is the first reported case of syringomatoid ductal hyperplasia occurring secondary to calcinosis cutis. This was an unusual case, which could have been interpreted in one of two ways. Either explanation is unlikely to have significantly altered the management of the patient, but resurfaces an interesting discussion point about the true nature of syringomas and whether they represent a reactive/hyperplastic phenomenon or are truly a neoplastic lesion. Despite showcasing a rare morphological phenomenon, this case serves to remind that all that is comma-shaped is not unequivocally syringoma. The diagnosis of a syringoma needs to be considered along with the clinical context and careful histological evaluation of background skin (for potential duct-inducing pathologies) before a diagnosis is made.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Umar A. Hussain, Jamie A. Tschen

Acquisition, analysis, or interpretation of data:  Umar A. Hussain, Audrey E. Ahuero, Jamie A. Tschen

Drafting of the manuscript:  Umar A. Hussain, Audrey E. Ahuero

Critical review of the manuscript for important intellectual content:  Umar A. Hussain, Audrey E. Ahuero, Jamie A. Tschen

Supervision:  Jamie A. Tschen
==== Refs
References

1 Syringoma. Histochemical and electron microscopic studies J Invest Dermatol Hashimoto K Gross BG Lever WF 150 166 46 1966 https://www.jidonline.org/article/S0022-202X(15)47066-6/pdf 4286059
2 Clinicopathological diversity of syringomas: a study on current clinical and histopathologic concepts Dermatoendocrinol Müller CS Tilgen W Pföhler C 282 288 1 2009 21572872
3 Proliferation of sweat ducts in certain diseases of the skin Am J Dermatopathol Mehregan AH 27 31 3 1981 7235196
4 'Eruptive syringoma': a misnomer for a reactive eccrine gland ductal proliferation? J Cutan Pathol Guitart J Rosenbaum MM Requena L 202 205 30 2003 12641781
5 Syringomatous changes of eccrine sweat ducts associated with prurigo nodularis Am J Dermatopathol Corredor F Cohen PR Tschen JA 296 301 20 1998 9650706
6 Proliferation of eccrine sweat ducts associated with alopecia areata J Cutan Pathol Barnhill RL Goldberg B Stenn KS 36 39 15 1988 3351061
7 Proliferation of eccrine sweat ducts associated with heterotopic neural tissue (nasal glioma) Am J Dermatopathol Gambini C Rongioletti F Rebora A 179 182 22 2000 10770442
8 Eruptive syringomas with calcium deposits in a young woman with Down's syndrome Dermatology Schepis C Torre V Siragusa M Albiero F Cicciarello R Gagliardi ME Cavallari V 345 347 203 2001 11752828
9 Milia with calcium deposits on the palms and soles in a patient with multiple syringoma Pediatr Dermatol Pereira LB Brandão FV Gontijo B 370 372 27 2010 20653855
10 Dystrophic calcinosis of the penis J Dermatol Katoh N Okabayashi K Wakabayashi S Kishimoto S Yasuno H 114 117 20 1993 7683026
11 Subsequent development of syringomas in a patient with milialike idiopathic calcinosis and without down syndrome Arch Dermatol Berk DR Lu D Lind AC Bayliss SJ 680 681 146 2010 20566940
12 A case of milium-like syringoma with focal calcification in Down syndrome Br J Dermatol Seo SH Oh CK Kwon KS Kim MB 612 614 157 2007 17553057
13 Multiple subepidermal calcified nodules on the eyelids with eruptive syringomas: a possible ethiopathogenic relationship J Eur Acad Dermatol Venereol Zeglaoui F Khaled A Fazaa B Riahi O Zermani R Kamoun MR 337 339 23 2009 18554217
14 Cutaneous syringoma: a clinicopathologic study of 34 new cases and review of the literature Indian J Dermatol Ghanadan A Khosravi M 326 58 2013
15 Milialike idiopathic calcinosis cutis and syringoma in Down's syndrome J Dermatol Kanzaki T Nakajima M 616 618 18 1991 1838753
16 Calcinosis cutis associated with syringomas: a transepidermal elimination disorder in a patient with Down syndrome J Am Acad Dermatol Maroon M Tyler W Marks VJ 372 375 23 1990 2144304
17 Calcinosis cutis: part I. Diagnostic pathway J Am Acad Dermatol Reiter N El-Shabrawi L Leinweber B Berghold A Aberer E 1 12 65 2011 21679810
